LumiThera Inc., (Seattle, Washington) announces initial European data on photobiomodulation (PBT) results for treatment of dry AMD
LumiThera Inc., based in Seattle, WA has reported positive results for a “LIGHTSITE II” study, (NCT NCT03878420) conducted by a multi-centre clinical trial in dry… Read More »LumiThera Inc., (Seattle, Washington) announces initial European data on photobiomodulation (PBT) results for treatment of dry AMD